Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.44 |
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | EGLN1 | Q9GZT9 | 5/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | APEX1 | P27695 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17629490 | 0.81 | EGLN1 (0.50) | PKMKDM4EALDH1A1POLBTSHR | |
| SCHEMBL17629620 | 0.78 | KDM4E (0.52) | PKMKDM4EALDH1A1POLBTSHR | |
| SCHEMBL17629646 | 0.78 | KDM4E (0.49) | PKMKDM4EALDH1A1POLBTSHR | |
| SCHEMBL19251706 | 0.76 | EGLN1 (0.52) | PKMKDM4EALDH1A1POLBTSHR | |
| SCHEMBL12777777 | 0.70 | EGLN1 (0.48) | PKMKDM4EALDH1A1NPC1RAB9A | |
| SCHEMBL3421207 | 0.69 | SLC22A12 (0.54) | KDM4EALDH1A1POLBHPGDMEN1 | |
| SCHEMBL821620 | 0.68 | KMT2A (0.76) | PKMKDM4EALDH1A1POLBNPC1 | |
| SCHEMBL4155293 | 0.67 | EGLN1 (0.57) | PKMKDM4EALDH1A1NPC1RAB9A | |
| SCHEMBL4154430 | 0.66 | EGLN1 (0.47) | PKMKDM4ENPC1RAB9AEGLN1 | |
| SCHEMBL5311454 | 0.66 | MEN1 (0.54) | PKMKDM4EALDH1A1POLBNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2257171-B1 | TETRAHYDRO-1H-PYRROLO-FUSED PYRIDONES | MERCK SHARP & DOHME (US) | 2016-02-10 | — | — | EP | disclosed |
| US-8372863-B2 | Tetrahydro-1H-pyrrolo fused pyridones | MERCK SHARP & DOHME CORP. (US) | 2013-02-12 | — | — | US | disclosed |
| US-20110009406-A1 | TETRAHYDRO-1H-PYRROLO FUSED PYRIDONES | MERCK SHARP & DOHME LLC | 2011-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110009406-A1 | TETRAHYDRO-1H-PYRROLO FUSED PYRIDONES | HIF1AN, EGLN2, EGLN3 | PKM 511/4885KDM4E 197/4885ALDH1A1 383/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.